1 research outputs found

    Transcriptional mechanism of vascular endothelial growth factor-induced expression of protein kinase CĪ²II in chronic lymphocytic leukaemia cells

    Get PDF
    A key feature of chronic lymphocytic leukaemia (CLL) cells is overexpressed protein kinase CĪ²II (PKCĪ²II), an S/T kinase important in the pathogenesis of this and other B cell malignancies. The mechanisms contributing to enhanced transcription of the gene coding for PKCĪ²II, PRKCB, in CLL cells remain poorly described, but could be important because of potential insight into how the phenotype of these cells is regulated. Here, we show that SP1 is the major driver of PKCĪ²II expression in CLL cells where enhanced association of this transcription factor with the PRKCB promoter is likely because of the presence of histone marks permissive of gene activation. We also show how vascular endothelial growth factor (VEGF) regulates PRKCB promoter function in CLL cells, stimulating PKCĪ² gene transcription via increased association of SP1 and decreased association of STAT3. Taken together, these results are the first to demonstrate a clear role for SP1 in the up regulation of PKCĪ²II expression in CLL cells, and the first to link SP1 with the pathogenesis of this and potentially other B cell malignancies where PKCĪ²II is overexpressed
    corecore